… The primary efficacy outcome was venous thromboembolism (which was a composite of
asymptomatic deep-vein thrombosis, confirmed symptomatic venous thromboembolism, or …

… special anatomical location of venous thrombosis [1] … vascular risk factors for arterial are not
risk factors for CVT, (9) has a different treatment, similar to systemic deep venous thrombosis, …

… In randomized trials, the incidence of deep-vein thrombosis was … guidelines recommend
pharmacologic thromboprophylaxis in all critically ill patients. However, deep-vein thrombosis …

… This study is not required by the FDA under the pediatric research … pediatric investigation
plan (PIP). The authors are solely responsible for the design and conduct of this study, all study …

… primary endpoint, and pulmonary embolism, fatal pulmonary embolism, and major bleeding
… effects of prevention on venous thromboembolism endpoints. We report treatment effects as …

… clotting time. In our survey, anti-Xa levels were the single preferred monitoring method in
pediatric… neonates and young children causes large variation in individual response to heparin. …

… keyword “Cerebral sinus venous thrombosis” was performed. We searched for the epidemiology,
risk factors, pathophysiology, clinical features, diagnosis, and treatment of CSVT. All full…

… A review of the management issues in vascular liver disorders specific to children and
guidance on early intervention in extrahepatic portal vein obstruction in children. …

… guideline, we summarize recommendations on definition, diagnosis, management, and
prevention of … This guideline supports clinicians and researchers alike in the evidence-based …

… Introduction about thrombotic thrombocytopenic purpura (TTP), the reasons why we … treatment
guidelines for TTP, how to use these guidelines, how to develop the treatment guidelines, …